BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6418181)

  • 1. Pharmacokinetics of a slow-release preparation of ketoprofen lysine in man.
    Borsa M; Tonon GC; Ronchi C; Zanolo G; Canali S
    Arzneimittelforschung; 1983; 33(10):1497-500. PubMed ID: 6418181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic profile of a slow-release ketoprofen preparation].
    Flouvat B; Stheneur A; Massias P
    Sem Hop; 1983 Dec; 59(46):3187-90. PubMed ID: 6318337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability study on a new slow-release formulation of ketoprofen.
    Caruso I; Frigerio E; Fumagalli M; Liverta C; Moro L; Tamassia V
    J Int Med Res; 1982; 10(4):229-33. PubMed ID: 7117681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacokinetic study of repeated doses of a new controlled release form of ketoprofen.
    Houghton GW; Dennis MJ; Templeton R; Calvert RM; Cresswell DG
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):131-3. PubMed ID: 6715081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacologic and pharmacokinetic activity of ketoprofen lysine salt for topical administration].
    Borsa M; Malandrino S; Ronchi C; Tonon GC; Zanolo G
    Farmaco Prat; 1983 Feb; 38(2):87-96. PubMed ID: 6403380
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative pharmacokinetics of ketoprofen derived from single oral doses of ketoprofen capsules or a novel sustained-release pellet formulation.
    Houghton GW; Dennis MJ; Rigler ED; Parsons RL
    Biopharm Drug Dispos; 1984; 5(3):203-9. PubMed ID: 6487749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary pharmacokinetics of orally administered ketoprofen in man.
    Houghton GW; Dennis MJ; Rigler ED; Parsons RL
    Eur J Drug Metab Pharmacokinet; 1984; 9(3):201-4. PubMed ID: 6519121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic profile of controlled release ketoprofen in elderly patients.
    Dennis MJ; French PC; Crome P; Babiker M; Shillingford J; Hopkins R
    Br J Clin Pharmacol; 1985 Dec; 20(6):567-73. PubMed ID: 4091989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian changes in the pharmacokinetics of oral ketoprofen.
    Ollagnier M; Decousus H; Cherrah Y; Levi F; Mechkouri M; Queneau P; Reinberg A
    Clin Pharmacokinet; 1987 May; 12(5):367-78. PubMed ID: 3608343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketoprofen pharmacokinetics and bioavailability based on an improved sensitive and specific assay.
    Upton RA; Williams RL; Guentert TW; Buskin JN; Riegelman S
    Eur J Clin Pharmacol; 1981; 20(2):127-33. PubMed ID: 7262174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical compatibility between ketoprofen lysine salt injections (Artrosilene) and pharmaceutical products frequently used for combined therapy by intravenous administration.
    Anacardio R; Perilli O; Bartolini S; Gentile MM; Mazzeo P; Carlucci G
    J Pharm Biomed Anal; 2003 Aug; 32(6):1235-41. PubMed ID: 12907268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, interpatient comparison of plain and slow-release ketoprofen in osteoarthritis.
    Marcolongo R; Rubegni M; Provvedi D; Giordano N; Frati E; Bruni G
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):377-81. PubMed ID: 6381334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the absorption of ketoprofen topically administered in man: comparison between tissue and plasma levels.
    Ballerini R; Casini A; Chinol M; Mannucci C; Giaccai L; Salvi M
    Int J Clin Pharmacol Res; 1986; 6(1):69-72. PubMed ID: 3957503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of meal size and composition on the bioavailability of ketoprofen (Oruvail).
    Nievel JG; Havard CW; Mitchell P; Gudgeon A; Kaye CM
    Xenobiotica; 1987 Apr; 17(4):487-92. PubMed ID: 3604255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative trial of a controlled-release formulation of ketoprofen ('Oruvail') and a conventional capsule formulation of ketoprofen ('Orudis') in patients with osteoarthritis of the hip.
    Morley KD; Bernstein RM; Hughes GR; Black CM; Rajapakse CN; Wilson L
    Curr Med Res Opin; 1984; 9(1):28-34. PubMed ID: 6723349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of ketoprofen in the synovial fluid].
    Kennedy AC
    Sem Hop; 1983 Dec; 59(46):3208-9. PubMed ID: 6318342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular bioavailability of ketoprofen lysine salt in horses.
    Anfossi P; Villa R; Montesissa C; Carli S
    Vet Q; 1997 Jun; 19(2):65-8. PubMed ID: 9225435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastric endoscopic assessment after treatment with orally administered ketoprofen lysine salt (80 mg granular sachet). Controlled study vs placebo].
    Fatti F; Ghirardini M; Martini A; de' Lorenzi C
    Minerva Med; 1994 Oct; 85(10):531-5. PubMed ID: 7800195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suprofen sustained release kinetics in healthy male volunteers. 1st communication: a single dose open crossover bioavailability study of suprofen sustained release tablets versus capsules.
    Michos N; Zulliger HW; Barkworth MF; Johnson KJ; Rehm KD; Töberich H; Klein G
    Arzneimittelforschung; 1986 Jun; 36(6):941-8. PubMed ID: 3741528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic pharmacokinetic studies of slow release ketoprofen (Oruvail) in rheumatoid arthritis.
    Christophidis N; Rotstein A; Louis WJ
    Clin Exp Pharmacol Physiol; 1986 Jul; 13(7):555-61. PubMed ID: 3791708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.